The New York Entrepreneur

Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

Read Time:7 Second

Drugmakers appear to be less concerned about the impact of negotiated prices on their businesses in the short term. Meanwhile, health care heads to Hollywood.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Rivian tops Wall Street’s second-quarter expectations amid cost cuts
Next post Upstart’s stock soars as fintech company’s CEO says comeback is in the works